New York, N.Y., February 29, 2024 - PRISM MarketView - Not only is Establishment Labs Holdings Inc. (ESTA) up 24% today, it’s also been steadily rising since the start of the year. The company who has been included in the PRISM Women’s Health Index since the indices’ inception on January 4th of this year, had traded around $25/share and is now approaching $50 with a current share price of $47.
PRISM MarketView Launches Emerging Women’s Health Index
Global women’s health market projected to reach $67.07 billion by 2031 Private equity investment in women’s health exceeded $3 billion in 2022 NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging Women’s Health Index. The growth of the women’s health market is accelerating with the introduction of next-generation therapeutics and artificial intelligence (AI) powered imaging a
Read More
Today's upward movement is likely attributed to its recent earnings announcement. Despite reporting a net loss, the company surpassed estimates and increased its revenue guidance. Over the past two months, Establishment Labs has announced an amended credit facility with Oaktree as well as its first US commercial procedure with its breast aesthetic and reconstructive product, the Motiva Flora® SmoothSilk® Tissue Expander. Additionally, the company has launched the product in China.
Establishment Labs Holdings is a global medical technology company that specializes in developing and commercializing innovative breast implant technologies. The company focuses on advanced breast aesthetics and reconstruction solutions, leveraging cutting-edge materials and techniques to provide safer, more natural-looking results for patients. Establishment Labs aims to revolutionize the breast implant industry through its commitment to research, development, and patient satisfaction.
About PRISM MarketView:
Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on Twitter.
PRISM MarketView does not provide investment advice.
Contact:
Prism MarketView | Stock Market News & Investment Opportunities
PRISM MarketView - Social Media (X)